Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer

PURPOSE: Biomarkers are essential to implement personalized therapies in cancer treatment options. As primary liver tumors are increasing and treatment is coupled to liver function and activation of systemic cells of the immune system, we investigated blood-based cells for their ability to predict r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kästle, Sophia, Stechele, Matthias R., Richter, Lisa, Schinner, Regina, Öcal, Elif, Alunni-Fabbroni, Marianna, De Toni, Enrico, Corradini, Stefanie, Seidensticker, Max, Goldberg, S. Nahum, Ricke, Jens, Wildgruber, Moritz, Kimm, Melanie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423129/
https://www.ncbi.nlm.nih.gov/pubmed/37247078
http://dx.doi.org/10.1007/s00432-023-04875-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423129/
https://www.ncbi.nlm.nih.gov/pubmed/37247078
http://dx.doi.org/10.1007/s00432-023-04875-z

Ejemplares similares